SBIR/STTR Research Award
Infrared Eyes(iREyes)
Award amount
$1,696,653Program and phase
SBIR · Phase IIAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Korosensor.Com, Inc.
- Proposal award date
- 2018-09-15
- Contract end date
- 2021-08-31
- UEI
- Not reported
- Solicitation number
- PA18-591
- Topic code
- 200
Research abstract
Infrared Eyes Abstract
Eden Medical, Inc. is pleased to submit this Phase 2 SBIR proposal to develop the “Infrared Eyes” (iREyes) imager system, an
affordable and powerful mobile health (mHealth) tool for healthcare. The hand-held iREyes system will acquire both thermal and
visible spectrum imagery to quantify healing via thermal indexing methodology. The iREyes will offer a user-friendly product with
automated categorization. Diabetic foot wounds are common, complex and costly. Foot areas that are likely to ulcerate are
associated with increased local skin temperature due to inflammation and enzymatic autolysis of tissue. Inflammation is
characterized by the cardinal signs including redness, swelling, and heat. The iREyes will also identify hot spots associated with
repetitive stress to reduce ulceration risk. iREyes will directly quantify inflammation pathophysiology through contralateral and
regional foot index image analysis. The automated categorization capability will improve diagnosis and enable medical
professionals to better track progress of wound healing as well as efficacy of treatment. This represents a significant improvement
over current practice. At the size of a 7-inch tablet, the iREyes combines visible and far infrared imaging into a mHealth solution
for wound clinics and treatment centers.Infrared Eyes Narrative
To develop a low-cost mobile health (mHealth) infrared imaging system that
acquires both thermal and visible spectrum imagery to quantify wound healing via
thermal indexing methodology.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Electromagnetic reprogramming of systemic metabolism for the treatment of type 2 diabetes
- Next-Gen Oral Therapeutics for Type 2 Diabetes
- Oral Therapeutics Platform for Treating Inborn Errors of Amino Acid Metabolism
- Development of novel therapeutics for obesity and type 2 diabetes
- Metrifonate local application for DFU treatment